FDA: Abbott’s Neck Stent Meets Primary Goals

Abbott Laboratories’ carotid stent met primary study goals for wider use, according to U.S. regulators weighing whether to expand the device’s approved use beyond patients who are too sick for surgery.
Bloomberg